ATP13A2: A New Avenue in Parkinson’s Research. Researcher in the Spotlight: Prof. Peter Vangheluwe
- Research Could ATP13A2 and polyamines unlock new insights into Parkinson’s disease? Prof. Peter Vangheluwe of KU Leuven explains how his research into cellular transport systems could help reveal new pathways for protecting brain cells and developing future Parkinson’s therapies.















